|
|
 |
|
| | |
| | | | | |
organism-gene
|
|
PR:P01008 |
antithrombin-III (human)
|
hSERPINC1
|
"An antithrombin-III that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01008]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-sequence
|
|
PR:P01008-1 |
antithrombin-III isoform 1 (human)
|
hSERPINC1/iso:1
|
"An antithrombin-III isoform 1 that is encoded in the genome of human." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000049206 |
antithrombin-III, signal peptide removed form (human)
|
hSERPINC1/SigPep-
|
"An antithrombin-III (human) that has had the signal peptide removed. UniProtKB:P01008, 33-464." [PRO:DNx, Reactome:R-HSA-140792, Reactome:R-HSA-140807]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000064430 |
antithrombin-III, signal peptide removed phosphorylated form (human)
|
hSERPINC1/SigPep-/PhosRes+
|
"An antithrombin-III (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P01008, 33-464, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957069]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051366 |
antithrombin-III N-glycosylated 1 (human)
|
hSERPINC1/NGlyco:1
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01008-1, Asn-128, MOD:00160~GNO:G00912UN." [GlyGen:P01008-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051367 |
antithrombin-III N-glycosylated 2 (human)
|
hSERPINC1/NGlyco:2
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P01008-1, Asn-128, MOD:00160~GNO:G42358LZ." [GlyGen:P01008-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051368 |
antithrombin-III N-glycosylated 3 (human)
|
hSERPINC1/NGlyco:3
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-187 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01008-1, Asn-187, MOD:00160~GNO:G00912UN." [GlyGen:P01008-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051369 |
antithrombin-III N-glycosylated 4 (human)
|
hSERPINC1/NGlyco:4
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-187 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P01008-1, Asn-187, MOD:00160~GNO:G22140GZ." [GlyGen:P01008-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051370 |
antithrombin-III N-glycosylated 5 (human)
|
hSERPINC1/NGlyco:5
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-187 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P01008-1, Asn-187, MOD:00160~GNO:G88374WZ." [GlyGen:P01008-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051371 |
antithrombin-III N-glycosylated 6 (human)
|
hSERPINC1/NGlyco:6
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-224 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01008-1, Asn-224, MOD:00160~GNO:G00912UN." [GlyGen:P01008-1, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051372 |
antithrombin-III O-glycosylated 1 (human)
|
hSERPINC1/OGlyco:1
|
"An antithrombin-III (human) that has been O-glycosylated at the residue equivalent to Thr-418 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01008-1, Thr-418, MOD:00005~GNO:G29068FM." [GlyGen:P01008-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000051373 |
antithrombin-III O-glycosylated 2 (human)
|
hSERPINC1/OGlyco:2
|
"An antithrombin-III (human) that has been O-glycosylated at the residue equivalent to Thr-418 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01008-1, Thr-418, MOD:00005~GNO:G43417UB." [GlyGen:P01008-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000064430 |
antithrombin-III, signal peptide removed phosphorylated form (human)
|
hSERPINC1/SigPep-/PhosRes+
|
"An antithrombin-III (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P01008, 33-464, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957069]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000071477 |
antithrombin-III cysteinylated 1 (human)
|
hSERPINC1/Cyst:1
|
"An antithrombin-III (human) that has been cysteinylated on the residue at the position equivalent to Cys-160 of the amino acid sequence represented by UniProtKB:P01008. UniProtKB:P01008, Cys-160, MOD:00765." [IEDB_epitope:2127384, PRO:DNx]
|
|
|
|
|
